Linda Baddour, Chief Financial Officer at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 55,479 shares at $31.69 ($1.8M) on 2006-11-10, disclosed to the SEC on 2006-11-14.
Open-market sale of $1.8M PPDI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.61 | 100 | $3K | 0.2% |
| 2 | $31.62 | 200 | $6K | 0.4% |
| 3 | $31.63 | 100 | $3K | 0.2% |
| 4 | $31.64 | 1,100 | $35K | 2.0% |
| 5 | $31.65 | 1,000 | $32K | 1.8% |
| 6 | $31.66 | 3,330 |
| $105K |
| 6.0% |
| 7 | $31.67 | 3,149 | $100K | 5.7% |
| 8 | $31.68 | 2,500 | $79K | 4.5% |
| 9 | $31.69 | 2,000 | $63K | 3.6% |
| 10 | $31.70 | 3,200 | $101K | 5.8% |
| 11 | $31.71 | 2,598 | $82K | 4.7% |
| 12 | $31.72 | 5,502 | $175K | 9.9% |
| 13 | $31.73 | 2,400 | $76K | 4.3% |
| 14 | $31.74 | 2,000 | $63K | 3.6% |
| 15 | $31.75 | 1,600 | $51K | 2.9% |
| 16 | $31.76 | 1,700 | $54K | 3.1% |
| 17 | $31.77 | 1,900 | $60K | 3.4% |
| 18 | $31.78 | 300 | $10K | 0.5% |
| 19 | $31.79 | 300 | $10K | 0.5% |
| 20 | $31.80 | 1,498 | $48K | 2.7% |
| 21 | $31.81 | 800 | $25K | 1.4% |
| 22 | $31.82 | 1,928 | $61K | 3.5% |
| 23 | $31.83 | 2,578 | $82K | 4.7% |
| 24 | $31.84 | 4,257 | $136K | 7.7% |
| 25 | $31.85 | 4,066 | $130K | 7.4% |
| 26 | $31.86 | 3,272 | $104K | 5.9% |
| 27 | $31.87 | 2,101 | $67K | 3.8% |
| Total | $31.76 avg | 55,479 | $1.8M | 100% |
| Filing → |
| WAT | SELL | 2021-05-14 | $787K | — | Filing → |
| PRAH | SELL | 2018-01-18 | $12.1M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $15.0M | — | Filing → |